Novel Approaches to Early Cancer Detection
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 298
Special Issue Editors
Interests: cancer detection
Interests: data science; machine learning in early detection
Interests: cancer biomarkers; metabolomics; metabolic vulnerabilities; therapeutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a leading cause of death, with over 10 million lives lost per year worldwide. Cancer screening has been instrumental in reducing cancer mortality. The foundational concept behind cancer screening is that cancer survival is more likely when cancers are diagnosed at earlier stages, when treatments have the potential to be more successful. Depending on the country, screening programs exist for a several cancer types. For example, the United States Preventive Services Task Force recommends (Grade A/B) the screening of four common cancers: breast, cervical, colorectal and lung cancers. However, that leaves about 2/3 of incident cancers for which no recommended screening options are available today. One of the approaches to overcome this challenge is to apply novel biomarker detection technologies and strategies to the blood and other bodily fluid samples for the identification of early-stage cancers. These new technologies have the potential to boost clinical performance and lower testing costs for single-organ screening. In addition, they enable the simultaneous detection of numerous cancer types via multi-cancer early detection (MCED) within a single sample.
This Special Issue is dedicated to the topic of early cancer detection and welcomes articles from experts in the field of single- and multi-cancer screening. The goal is to compile broad perspectives and the latest advances related to this field, including areas such as clinical development and biomarker research. This Special Issue should inspire readers to get involved in this impactful and rapidly changing field. Together, we can save lives by making novel and better cancer screening tests part of routine medical care.
Dr. Frank Diehl
Dr. Christopher Blair Douville
Dr. Johannes Fahrmann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multi-cancer early detection
- screening
- early detection
